Olmutinib, CAS 1353550-13-6

Product Description: Olmutinib (HM61713; BI-1482694) is an orally active and irreversible third EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain. Olmutinib is used for NSCLC[1][2].

Applications: Cancer-Kinase/protease

Formula: C26H26N6O2S

References: [1]Kim ES, et al. Olmutinib: First Global Approval. Drugs. 2016 Jul;76(11):1153-7./[2]Mohamed W. Attwa, et al. Detection and characterization of olmutinib reactive metabolites by LC‐MS/MS: Elucidation of bioactivation pathways. Journal of Separation science. 18 November 2019.

CAS Number: 1353550-13-6

Molecular Weight: 486.59

Compound Purity: 99.88

Research Area: Cancer

Solubility: DMSO : 125 mg/mL (ultrasonic)

Target: EGFR

• SKU: MEXHY-19730-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-19730-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK